Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

doi:10.1182/blood-2015-06-651562

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

Blood - 22 Oct 2015

Schmid Christoph, Labopin Myriam, Socié Gerard, Daguindau Etienne, Volin Liisa, Huynh Anne, Bourhis Jean Henri, Milpied Noel, Cornelissen Jan, Chevallier Patrice, Maertens Johan, Jindra Pavel, Blaise Didier, Lenhoff Stig, Ifrah Norbert, Baron Frédéric, Ciceri Fabio, Gorin Claude, Savani Bipin, Giebel Sebastian, Polge Emmanuelle, Esteve Jordi, Nagler Arnon, Mohty Mohamad

Abstract excerpt

To analyze the influence of distinct combinations of molecular aberrations on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for cytogenetically normal acute myeloid leukemia (CN-AML), a retrospective registry analysis was performed on 702 adults undergoing HSCT in first complete remission (CR). Patients were grouped according to presence or absence of NPM1 mutations (NPM1(mut)) and FLT3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetic Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to Graft vs Host Disease

Share to Nucleophosmin

Share to Remission Induction

Share to Survival Rate

Share to Tandem Repeat Sequences

Share to Transplantation, Homologous

Source

Open in PubMed

Identifiers

PMID: 26351297
DOI: 10.1182/blood-2015-06-651562

Genes

FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.PMID 26351297Read ↗

Prognostic implication of molecular aberrations in cytogenetically normal acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.Semantic proximity Read ↗

Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations.Semantic proximity Read ↗

Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.Semantic proximity Read ↗

Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeSemantic proximity Read ↗

Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.Semantic proximity Read ↗

Combination of FLT3-ITD Allelic Ratio, NPM1 Mutation, and Immunophenotypic Markers to Modulate Outcome Prediction in Patients with Normal Karyotype Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation.Semantic proximity Read ↗

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.Semantic proximity Read ↗

Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD).Semantic proximity Read ↗

Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.Semantic proximity Read ↗

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.